William Strohl - 08 Aug 2024 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 Aug 2024, 20:30:55 UTC
Prior SEC filing
14 Mar 2024
Next SEC filing
14 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Misbah Tahir, by power of attorney

Key filing fact

William Strohl filed Form 4 for IGM Biosciences, Inc. (IGMS) on 12 Aug 2024.

Key facts

  • This page summarizes William Strohl's Form 4 filing for IGM Biosciences, Inc. (IGMS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Aug 2024, 20:30.

Change

  • Previous filing in this sequence was filed on 14 Mar 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IGMS transaction

Common Stock

Award

Transaction value
$0
Shares
+125,000
Change %
Price
$0.000000
Shares after
125,000
Date
08 Aug 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-eighth of the RSUs shall vest on each of August 15, 2024, October 31, 2024, January 31, 2025, April 30, 2025, July 31, 2025, October 31, 2025, January 31, 2026 and April 30, 2026, subject to the Reporting Person continuing to provide consulting services to the Issuer through each such date. Vested RSUs will be delivered to the Reporting Person on the earlier of (i) the first quarterly release date (March 12, June 12, September 12 or December 12) following the Reporting Person's separation from service with the Issuer or (ii) immediately prior to a change in control of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .